Published in J Exp Med on July 01, 1980
Identifying Foxp3-expressing suppressor T cells with a bicistronic reporter. Proc Natl Acad Sci U S A (2005) 5.96
Variable chimerism, graft-versus-host disease, and tolerance after different kinds of cell and whole organ transplantation from Lewis to brown Norway rats. Transplantation (1995) 3.63
Haplotype-specific suppression of cytotoxic T cell induction by antigen inappropriately presented on T cells. J Exp Med (1983) 1.31
In vivo administration of interleukin 2 plus T cell-depleted syngeneic marrow prevents graft-versus-host disease mortality and permits alloengraftment. J Exp Med (1990) 1.13
Targeting the CXCR4-CXCL12 axis mobilizes autologous hematopoietic stem cells and prolongs islet allograft survival via programmed death ligand 1. J Immunol (2010) 1.04
The effects of chimeric cells following donor bone marrow infusions as detected by PCR-flow assays in kidney transplant recipients. J Clin Invest (1997) 1.02
Split tolerance induced by the intrathymic adoptive transfer of thymocyte stem cells. J Exp Med (1988) 0.92
The surprising kinetics of the T cell response to live antigenic cells. J Immunol (2007) 0.90
Functional heterogeneity in allospecific cytotoxic T lymphocyte clones. I. CTL clones express strong anti-self suppressive activity. J Exp Med (1984) 0.87
Clonal deletion of postthymic T cells: veto cells kill precursor cytotoxic T lymphocytes. J Exp Med (1992) 0.85
Cloning of self-major histocompatibility complex antigen-specific suppressor cells from adult bone marrow. J Exp Med (1990) 0.83
T cell tolerance to non-H-2-encoded stimulatory alloantigens is induced intrathymically but not prethymically. J Exp Med (1983) 0.81
Autoimmune syndrome after induction of neonatal tolerance to alloantigens: analysis of the role of donor T cells in the induction of autoimmunity. Clin Exp Immunol (1990) 0.79
The use of donor-derived veto cells in hematopoietic stem cell transplantation. Front Immunol (2012) 0.78
AKR.H-2b lymphocytes inhibit the secondary in vitro cytotoxic T-lymphocyte response of primed responder cells to AKR/Gross murine leukemia virus-induced tumor cell stimulation. J Virol (1996) 0.77
Hybrid antibody mediated veto of cytotoxic T lymphocyte responses. J Exp Med (1996) 0.77
Cell-mediated cytotoxicity, allograft rejection, and tumor immunity. Adv Immunol (1974) 11.12
On the thymus in the differentiation of "H-2 self-recognition" by T cells: evidence for dual recognition? J Exp Med (1978) 9.51
The somatic generation of immune recognition. Eur J Immunol (1971) 6.80
THE NATURAL HISTORY OF AUTOIMMUNE DISEASE IN NZB MICE. A COMPARISON WITH THE PATTERN OF HUMAN AUTOIMMUNE MANIFESTATIONS. Ann Intern Med (1963) 4.22
H-2 antigens of the thymus determine lymphocyte specificity. J Exp Med (1978) 3.91
Differential function of major histocompatibility complex antigens in T-lymphocyte activation. Nature (1976) 3.87
Immunological circuits: cellular composition. Fed Proc (1979) 3.72
THE EFFICIENT DESIGN OF TRANSPLANTABLE TUMOUR ASSAYS. Br J Cancer (1963) 3.66
The in vitro generation and sustained culture of nude mouse cytolytic T-lymphocytes. J Exp Med (1979) 3.15
Disordered immunologic regulation and autoimmunity. Transplant Rev (1976) 2.62
Induction of T lymphocytes from precursor cells in vitro by a product of the thymus. J Exp Med (1973) 2.43
Quantitative studies of the activation of cytotoxic lymphocyte precursor cells. Immunol Rev (1977) 1.87
Quantitative analysis of the 51Cr release cytotoxicity assay for cytotoxic lymphocytes. Cell Immunol (1974) 1.68
Quantitative studies on the precursors of cytotoxic lymphocytes. I. Characterization of a clonal assay and determination of the size of clones derived from single precursors. J Immunol (1977) 1.57
Self-tolerance maintained by active suppressor mechanisms. Transplant Rev (1976) 1.56
Primary in vitro cell-mediated lympholysis reaction of NZB mice against unmodified targets syngeneic at the major histocompatibility complex. J Exp Med (1978) 1.45
The tolerant cell: direct evidence for receptor blockade by tolerogen. J Immunol (1974) 1.35
A cell population in nu/nu spleen can prevent generation of cytotoxic lymphocytes by normal spleen cells against self antigens of the nu/nu spleen. J Immunol (1979) 1.10
Phytohemagglutinin-induced differentiation and blastogenesis of precursor T cells from mouse bone marrow. J Exp Med (1977) 1.07
The immunoregulatory role of bone marrow. II. Characterization of a suppressor cell inhibiting the in vitro antibody response. Cell Immunol (1979) 1.06
Purification and characterization of mouse brain Thy-1 glycoprotein antigens. J Immunol (1978) 0.95
Differentiation of Thy 1-bearing cells from progenitors in long-term bone marrow cultures. J Immunol (1980) 0.93
In vitro studies on lymphocyte differentiation. II. Generation of terminal deoxynucleotidyl transferase-positive cells in long-term cultures of mouse bone marrow. J Immunol (1979) 0.93
Hypothesis. T-cell tolerance--one signal? Cell Immunol (1979) 0.92
The immunoregulatory role of bone marrow. I. Suppression of the induction of antibody responses to T-dependent and T-independent antigens by cells in the bone marrow. Cell Immunol (1979) 0.87
Characterization of in vitro T-lymphocyte colonies from spleens of nude mice. J Immunol (1979) 0.85
The production of hemopoietic growth factors by PHA-stimulated leukocytes. Exp Hematol (1978) 0.84
Graft-versus-host reaction-like phenomenon induced by BCG in mice lethally irradiated and transferred with syngeneic bone marrow cells. Cell Immunol (1977) 0.79
El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord (2000) 15.38
Separation of cells by velocity sedimentation. J Cell Physiol (1969) 8.73
The identification in adult bone marrow of pluripotent and restricted stem cells of the myeloid and lymphoid systems. J Exp Med (1977) 4.44
Extracorporeal membrane oxygenation in severe acute respiratory failure. A randomized prospective study. JAMA (1979) 3.69
Initiation of antibody production to sheep erythrocytes in vitro: replacement of the requirement for T-cells with a cell-free factor isolated from cultures of lymphoid cells. J Immunol (1972) 2.83
Practice parameter: immunotherapy for Guillain-Barré syndrome: report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology (2003) 2.76
Functional status of cells from lymphoid and myeloid tissues in mice with severe combined immunodeficiency disease. J Immunol (1984) 2.56
Multifocal motor neuropathy: response to human immune globulin. Ann Neurol (1993) 2.32
In the absence of renal disease, 20 year mortality risk in type 1 diabetes is comparable to that of the general population: a report from the Pittsburgh Epidemiology of Diabetes Complications Study. Diabetologia (2010) 2.22
Normal dystrophin transcripts detected in Duchenne muscular dystrophy patients after myoblast transplantation. Nature (1992) 2.22
Subacute, reversible motor neuron disease. Neurology (1991) 2.20
A multicenter, randomized, double-blinded trial of pyridostigmine in postpolio syndrome. Neurology (1999) 2.16
Reliability of the thermodilution method in the determination of cardiac output in clinical practice. Am Rev Respir Dis (1982) 2.07
Blunted pressor and intramuscular metabolic responses to voluntary isometric exercise in multiple sclerosis. J Appl Physiol (1985) (2000) 2.04
Allograft immunity in the mouse. II. Physical studies of the development of cytotoxic effector cells from their immediate progenitors. J Immunol (1973) 1.89
Quantitative studies of the activation of cytotoxic lymphocyte precursor cells. Immunol Rev (1977) 1.87
What price Kaplan-Meier? Biometrics (1983) 1.73
A quantitative assay for the progenitors of bone marrow-associated lymphocytes. J Exp Med (1972) 1.69
Quantitative analysis of the 51Cr release cytotoxicity assay for cytotoxic lymphocytes. Cell Immunol (1974) 1.68
Retrograde dissection of the temporalis muscle preventing muscle atrophy for pterional craniotomy. Technical note. J Neurosurg (1996) 1.65
Cyclosporine increases muscular force generation in Duchenne muscular dystrophy. Neurology (1993) 1.61
Placebo-controlled phase I/II studies of minocycline in amyotrophic lateral sclerosis. Neurology (2004) 1.60
Rapamycin enhances apoptosis and increases sensitivity to cisplatin in vitro. Cancer Res (1995) 1.57
Quantitative studies on the precursors of cytotoxic lymphocytes. I. Characterization of a clonal assay and determination of the size of clones derived from single precursors. J Immunol (1977) 1.57
Temporal patterns in overweight and obesity in Type 1 diabetes. Diabet Med (2010) 1.56
Central basis of muscle fatigue in chronic fatigue syndrome. Neurology (1993) 1.52
Prognosis in AZT myopathy. Neurology (1991) 1.50
Differentiation of rosette-forming cells from myeloid stem cells. J Immunol (1970) 1.49
Homogeneity of antibody-producing cells as analysed by their buoyant density in gradients of Ficoll. Immunology (1970) 1.45
Changes in glycaemic control and risk of coronary artery disease in type 1 diabetes mellitus: findings from the Pittsburgh Epidemiology of Diabetes Complications Study (EDC). Diabetologia (2007) 1.44
In vivo requirement for a radiation-resistant cells in the immune response to sheep erythrocytes. J Exp Med (1971) 1.41
CD28 costimulation inhibits TCR-induced apoptosis during a primary T cell response. J Immunol (1996) 1.41
An immunological suppressor cell inactivating cytotoxic T-lymphocyte precursor cells recognizing it. Nature (1980) 1.40
Diuresis in the ascitic patient: a randomized controlled trial of three regimens. J Clin Gastroenterol (1981) 1.39
Hoechst 33342 dye uptake as a probe of membrane permeability changes in mammalian cells. Proc Natl Acad Sci U S A (1981) 1.37
Atomic force microscopy of purple membranes. J Microsc (1988) 1.35
Identification by density separation of antigen-specific surface receptors on the progenitors of antibody-producing cells. Immunology (1971) 1.35
The use and abuse of filipin to localize cholesterol in membranes. Cell Biol Int Rep (1984) 1.29
Religation of the T cell receptor after primary activation of mature T cells inhibits proliferation and induces apoptotic cell death. J Immunol (1993) 1.27
The cubital tunnel syndrome: diagnosis and precise localization. Ann Neurol (1979) 1.25
Allograft immunity in the mouse. 1. Quantitation and specificity of cytotoxic effector cells after in vitro sensitization. J Immunol (1973) 1.25
Quantitative MR relaxometry study of muscle composition and function in Duchenne muscular dystrophy. J Magn Reson Imaging (1994) 1.24
Particle rosettes in the periaxonal Schwann cell membrane and particle clusters in the axolemma of rat sciatic nerve. Brain Res (1977) 1.23
Specific T cell receptor gene rearrangements at the site of muscle degeneration in Duchenne muscular dystrophy. J Immunol (1994) 1.23
Cell separation analysis of B and T lymphocyte differentiation. Transplant Rev (1975) 1.21
The natural history of amyotrophic lateral sclerosis. Neurology (1993) 1.21
Reconstitution of T cell-depleted spleen cell populations by factors derived from T cells. 3. Mechanism of action of T cell-derived factors. J Immunol (1973) 1.20
Evaluation of distal symmetric polyneuropathy: the role of autonomic testing, nerve biopsy, and skin biopsy (an evidence-based review). Muscle Nerve (2009) 1.19
A preliminary evaluation of a prospective study of pulmonary function studies and symptoms of hypoventilation in ALS/MND patients. J Neurol Sci (2001) 1.19
Cell cycle distribution of chronically hypoxic cells and determination of the clonogenic potential of cells accumulated in G2 + M phases after irradiation of a solid tumor in vivo. Cancer Res (1979) 1.19
Strength, skeletal muscle composition, and enzyme activity in multiple sclerosis. J Appl Physiol (1985) (1997) 1.16
Chlorine dioxide water disinfection: a prospective epidemiology study. Arch Environ Health (1981) 1.16
A method to codetect introduced genes and their products in gene therapy protocols. Nat Biotechnol (1996) 1.16
CYP52 (cytochrome P450alk) multigene family in Candida maltosa: identification and characterization of eight members. DNA Cell Biol (1995) 1.15
Synchronization of mouse L-cells by a velocity sedimentation technique. Biophys J (1970) 1.15
Nerve conduction studies in infants and children. J Child Neurol (1986) 1.14
Alloreactive cytotoxic T cells can develop and function in mice lacking both CD4 and CD8. Eur J Immunol (1993) 1.14
Opposite polarity of filipin-induced deformations in the membrane of condensing vacuoles and zymogen granules. Science (1980) 1.13
Motor conduction studies in Guillain-Barré syndrome: description and prognostic value. Ann Neurol (1988) 1.13
Mitogenic analysis of murine B-cell heterogeneity. J Exp Med (1978) 1.13
Early detection and longitudinal changes in amyotrophic lateral sclerosis by (1)H MRSI. Neurology (2002) 1.12
Growth of two strains of Mycobacterium bovis (BCG) in athymic mice. J Gen Microbiol (1977) 1.12
Adiposity and mortality in type 1 diabetes. Int J Obes (Lond) (2009) 1.12
Early and late volume changes during erythroid differentiation of cultured Friend leukemic cells. J Cell Physiol (1977) 1.11
Sedimentation analysis of the cells in mice required to initiate an in vivo immune response to sheep erythrocytes. Proc Soc Exp Biol Med (1970) 1.11
Hybrid resistance in vitro. Possible role of both class I MHC and self peptides in determining the level of target cell sensitivity. J Immunol (1992) 1.10
A cell population in nu/nu spleen can prevent generation of cytotoxic lymphocytes by normal spleen cells against self antigens of the nu/nu spleen. J Immunol (1979) 1.10
Palliative care in amyotrophic lateral sclerosis. Neurol Clin (2001) 1.10
Central core disease: ultrastructure of the sarcoplasmic reticulum and T-tubules. Muscle Nerve (1989) 1.09
The effects of infusion of arginine vasopressin, oxytocin, or their antagonists into the olfactory bulb upon social recognition responses in male rats. Peptides (1998) 1.09
Growth at limiting dilution of human T cell colonies from T cell-depleted peripheral blood leukocytes. J Immunol (1983) 1.09
Toward earlier diagnosis of amyotrophic lateral sclerosis: revised criteria. rhCNTF ALS Study Group. Neurology (1998) 1.09
Evaluation of distal symmetric polyneuropathy: the role of laboratory and genetic testing (an evidence-based review). Muscle Nerve (2009) 1.09
Cellular elements in the resistance to candida infection in mice. I. Contribution of T lymphocytes and phagocytes at various stages of infection. Microbiol Immunol (1977) 1.09
Decreased N-acetylaspartate in motor cortex and corticospinal tract in ALS. Neurology (1998) 1.09
In vitro differentiation of B lymphocytes from pre-B cells. J Immunol (1979) 1.09
Muscle membrane excitation and impulse propagation velocity are reduced during muscle fatigue. Muscle Nerve (1986) 1.08
Acquisition of concomitant oral and genital infection with herpes simplex virus type 2. Sex Transm Dis (1987) 1.08
Quantitative studies on the precursors of cytotoxic lymphocytes. VI. Second signal requirements of specifically activated precursors isolated 12 h after stimulation. J Exp Med (1980) 1.08
Quantitative studies on the precursors of cytotoxic lymphocytes. V. The cellular basis for the cross-reactivity of TNP-specific clones. J Immunol (1978) 1.07
Programmed cell death of T cells signaled by the T cell receptor and the alpha 3 domain of class I MHC. Science (1991) 1.06
Linkage of Miyoshi myopathy (distal autosomal recessive muscular dystrophy) locus to chromosome 2p12-14. Neurology (1995) 1.06
Restriction of specificity in the precursors of bone marrow-associated lymphocytes. J Exp Med (1973) 1.05
Peripheral tolerance through clonal deletion of mature CD4-CD8+ T cells. Int Immunol (1992) 1.05
N-Shc and Sck, two neuronally expressed Shc adapter homologs. Their differential regional expression in the brain and roles in neurotrophin and Src signaling. J Biol Chem (1998) 1.05
Sporadic distal myopathy with early adult onset. Ann Neurol (1979) 1.05
Prenatal nicotine exposure affects the development of the central serotonergic system as well as the dopaminergic system in rat offspring: involvement of route of drug administrations. Brain Res Dev Brain Res (1997) 1.05
Volume analysis of human peripheral blood leukocytes. Ser Haematol (1972) 1.05
A developmentally regulated and psychostimulant-inducible novel rat gene mrt1 encoding PDZ-PX proteins isolated in the neocortex. Mol Psychiatry (2003) 1.05
Current management of ALS: comparison of the ALS CARE Database and the AAN Practice Parameter. The American Academy of Neurology. Neurology (2001) 1.05
Membrane particles on fracture faces of frozen myelin. Proc Natl Acad Sci U S A (1975) 1.04
Distal symmetrical polyneuropathy: definition for clinical research. Muscle Nerve (2005) 1.04
Marrow environment not required for differentiation of B lymphocytes. Nature (1974) 1.04
Functional significance of upper and lower motor neuron impairment in amyotrophic lateral sclerosis. Muscle Nerve (1998) 1.03